Long noncoding RNA lnc‐H2AFV‐1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the most common malignant tumor in the oral and maxillofacial regions, and long noncoding RNAs (lncRNAs) play crucial roles in the occurrence and progression of HNSCC. The lncRNA lnc‐H2AFV‐1 was found to be upregulated in HNSCC tissues; however, the function of lnc‐H2AFV‐1 in regulating HNSCC proliferation and the potential molecular mechanism is unclear. The present study evaluated the expression of lnc‐H2AFV‐1 in HNSCC tissues using quantitative real‐time PCR (qPCR) and associated abundant lnc‐H2AFV‐1 expression with tumor size. Functionally, lnc‐H2AFV‐1 significantly promoted the proliferation of HNSCC cells in vitro and in vivo. Quantified N6‐methyladenosine (m6A) RNA methylation and dot blot assays revealed that total m6A methylation in HNSCC cells was accompanied by lnc‐H2AFV‐1 expression. Western blotting showed that the expression of methyltransferase‐like (METTL) 3 and METTL14 was consistent with that of lnc‐H2AFV‐1, whereas the expression of demethylase fat mass and obesity‐associated (FTO) was contrary to that of lnc‐H2AFV‐1. Methylated RNA immunoprecipitation sequencing (MeRIP‐seq) and MeRIP‐qPCR revealed that lnc‐H2AFV‐1 overexpression led to the elevated expression and maximal m6A methylation of intraflagellar transport (IFT) 80 in HNSCC. In addition, METTL3/14 knockdown decreased IFT80 expression. Thus, our findings suggested that lnc‐H2AFV‐1 might be a biomarker that alters m6A modification by regulating the m6A methylases METTL3/14 and FTO and then mediating the downstream target IFT80 to promote HNSCC progression.